TozinameranMyocarditis, multisystem inflammatory syndrome and pericarditis: 10 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2023年 / 1969卷 / 1期
关键词：
D O I：
10.1007/s40278-023-44817-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：351 / 352
页数：1
相关论文
共 50 条
  • [41] ElasomeranAdult multisystem inflammatory syndrome: case report
    Reactions Weekly, 2022, 1896 (1) : 195 - 195
  • [42] A Japanese case of multisystem inflammatory syndrome in children
    Ogihara, Ayumi
    Miyata, Yohane
    Hosaki, Akira
    Narita, Masami
    Yan, Kunimasa
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [43] A Case of Multisystem Inflammatory Syndrome in an Immunosuppressed Adult
    Razzak, Abrahim N.
    Janardan, Abhishek
    Shah, Ipsit
    Jha, Pinky
    Abdelgadir, Yasir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [44] ElasomeranAdult multisystem inflammatory syndrome: case report
    Reactions Weekly, 2022, 1896 (1) : 196 - 196
  • [45] Case report: multisystem inflammatory syndrome in adults
    Cinco, Ryan
    Lam, Lai
    RESPIROLOGY, 2023, 28 : 388 - 388
  • [46] Multisystem inflammatory syndrome in children: a case series
    Gaspar, Arianne Ditzel
    Kuzma, Gabriela de Sio Puetter
    Amancio, Luana
    Floriani, Idilla
    Bezerra, Vinicius Neves
    Bortolon, Gabriela Cristina
    Siqueira, Ana Paula Viana de
    Machado, Maura Peruchi
    Machado, Ana Cristina dos Santos
    Camargo, Camila Faversani
    Joao, Paulo Ramos David
    REVISTA PAULISTA DE PEDIATRIA, 2022, 40
  • [47] TozinameranMyocarditis and dilated cardiomyopathy: 3 case reports
    Reactions Weekly, 2023, 1951 (1) : 305 - 305
  • [48] Pericarditis in 100% of patients with covid-19 as a manifestation of the multisystem inflammatory syndrome in adults
    Sukmar, Zulfiya
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 308 - 309
  • [49] BlinatumomabTumour lysis syndrome and pericarditis: 2 case reports
    Reactions Weekly, 2018, 1710 (1) : 70 - 70
  • [50] TozinameranMyocarditis and lack of efficacy: 2 case reports
    Reactions Weekly, 2023, 1969 (1) : 350 - 350
12345